InvestorsHub Logo
Followers 0
Posts 1158
Boards Moderated 0
Alias Born 01/17/2007

Re: None

Friday, 02/16/2007 1:58:14 PM

Friday, February 16, 2007 1:58:14 PM

Post# of 185857
In ONCM and The Old news

.0019 Should move higher IMO.

February 12, 2007 - 10:02 AM EST


ONCM 0.0018 0.0007
Today 5d 1m 3m 1y 5y 10y

Oncology Med, Inc.'s Merger Partner, Haz Holdings, Inc., Announces Agreement between Its Hotel Marquis & Suites and Certain Airlines to Provide Passenger Accomodations

Oncology Med, Inc. (OTC: ONCM) (“Oncology Med” or the “Company”), today announced that Hotel Marquis & Suites (“Hotel Marquis”) (www.hazhotels.com), the wholly-owned hotel chain of its merger partner, Haz Holdings, Inc., a Delaware corporation (“Haz Holdings”), has entered into agreements with Air France, American Airlines, China Airlines and Continental Airlines to provide accommodations to stranded air travelers who are booked on flights departing from George Bush Intercontinental Airport in Houston, Texas and San Antonio International Airport in San Antonio, Texas.

Under the agreements, passengers on these airlines whose flights are overbooked, delayed for an extended period and/or cancelled are entitled to receive vouchers good for a complimentary room at either the Hotel Marquis and Suites Intercontinental Airport hotel in Houston or the Hotel Marquis Airport in San Antonio. Hotel Marquis bills the airlines for those rooms issued to passengers presenting vouchers upon check-in.

Karim Bhanji, CEO of Haz Holdings Inc., stated, “We are delighted that these airlines have chosen Hotel Marquis to provide accommodations to passengers who may face unexpected changes in their travel plans.”

The Company announced on February 5, 2007 that it has entered into an agreement to merge a wholly-owned subsidiary of the Company into Haz Holdings, Inc. The Company expects the merger to be completed sometime in March 2007.

About Haz Holdings, Inc.

Haz Holdings owns and manages three mid-scale, full-service hotels in the United States and Canada, under the brand names “Hotel Marquis & Suites” and “Marquis Inn & Suites.” Its existing portfolio includes the 174-room Hotel Marquis and Suites Intercontinental Airport hotel in Houston, Texas, the 203-room Hotel Marquis Airport in San Antonio, Texas, and the Marquis Inn & Suites, a 30-room economy hotel with 70 recreational vehicle units in Edmonton, Alberta, Canada.

Management for Haz Holdings estimates its hotel portfolio current market value of $16 million dollars. Haz Holdings estimated 2006 year revenue of approximately $4 million dollars.

Additionally, Haz Holdings wholly-owns four subsidiary businesses: Mortgage and Financial Institute, LLC, an early stage mortgage broker in commercial and residential lending in Washington and Alaska, Nationwide Hotel Management, LLC, a hotel management company, KB Realty Group International, LLC, a commercial and residential real estate sales company, and Evergreen Sound Construction, LLC, a commercial and residential development company.

More information about Haz Holdings, Inc. can be found at http://www.hazholdings.com.

About Oncology Med, Inc.

Oncology Med, f/k/a, Nannaco, Inc., previously provided surface cleaning, surface protection, surface restoration and other services to commercial and industrial businesses, as well as to owners of historical buildings. The company has subsequently sought to improve its financial position through the acquisition of, or merger with, companies capable of providing the best value to its shareholders.

NOTE: This press release may contain "forward-looking statements." In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "potential," "continue" or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, competition, expected activities and expenditures as we pursue our business plan, and the adequacy of our available cash resources. Although we believe that the expectations reflected in any forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in these forward-looking statements. Changes in the circumstances upon which we base our predictions and/or forward-looking statements could materially affect our actual results. Additional factors that could materially affect these forward-looking statements and/or predictions include, among other things: (1) the company’s ability to manage its current merger transaction; (2) the company's limited operating history; (3) the company's ability to pay down existing debt; (4) the company's ability to secure necessary financing for its property acquisitions; (5) potential litigation by shareholders and/or former or current advisors against the company; (6) the company's ability to comply with federal, state and local government regulations and/or unforeseen changes in federal or and government regulations; and (7) the risks inherent in the investigation and consummation of the acquisition of a new business opportunity or other factors over which we have little or no control.

For Oncology Med, Inc., Seattle
18KT.TV, LLC. D/b/a EquityDigest.com
Joseph Malone, 786-375-0556
Information@EquityDigest.com

Source: Business Wire (February 12, 2007 - 10:02 AM EST)

News by QuoteMedia
www.quotemedia.com
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.